Johnson & Johnson H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 New Brunswick, NJ HQ📍 Raritan, NJ most H-1B filings🌐 jnj.com
Does Johnson & Johnson sponsor H-1B visas and green cards?
Yes. Johnson & Johnson has filed 556 H-1B LCAs and 92 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 Johnson & Johnson filed 118 H-1B LCAs at a median base salary of $160,000, about 31% above the national H-1B median of $121,966 for the same period, and 38 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 54 | $169k |
| FY2025 | 64 | $155k |
| FY2024 | 78 | $154k |
| FY2023 | 101 | $148k |
| FY2022 | 76 | $144k |
| FY2021 | 67 | $135k |
| FY2020 | 35 | $107k |
| FY2019 | 35 | $128k |
| FY2018 | 30 | $134k |
| FY2017 | 16 | $131k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 17 | $148k |
| FY2025 | 21 | $145k |
| FY2024 | 11 | $157k |
| FY2023 | 9 | $135k |
| FY2022 | 12 | $125k |
| FY2021 | 5 | $136k |
| FY2020 | 10 | $126k |
| FY2019 | 3 | $103k |
| FY2018 | 1 | $119k |
| FY2017 | 3 | $121k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 4,347
- US patents
- Published, not yet granted
- 1,613
- applications
- Most recent grant
- April 7, 2026
- Top area
- Filters implantable into blood vessels; prostheses664
Pay against the local market
Johnson & Johnson’s 10 most-filed occupations and metros. Its median base salary is 127% of the local BLS median for the same work.
| Occupation | Metro | Filings | Johnson & Johnson pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Computer Occupations, All Other | New York, NY | 73 | $145,110 | $109,990 | 132% |
| Software Developers | New York, NY | 35 | $150,706 | $148,011 | 102% |
| Software Developers | Tampa, FL | 17 | $129,218 | $111,331 | 116% |
| Computer and Information Systems Managers | New York, NY | 17 | $174,143 | $206,323 | 84% |
| Data Scientists | New York, NY | 17 | $142,406 | $131,716 | 108% |
| Data Scientists | Trenton, NJ | 13 | $149,325 | $131,108 | 114% |
| Medical Scientists | Jacksonville, FL | 11 | $160,382 | $77,834 | 206% |
| Electrical Engineers | Jacksonville, FL | 10 | $116,578 | $105,242 | 111% |
| Financial Managers | New York, NY | 9 | $223,056 | $210,450 | 106% |
| Software Developers | Philadelphia, PA | 9 | $143,784 | $121,712 | 118% |
About Johnson & Johnson
Johnson & Johnson is a pharma & biotech company based in New Brunswick, NJ. It was founded in 1886 and has about 136,400 employees worldwide. It is listed on NYSE as JNJ.
- Name (DOL filings)
- Johnson & Johnson
- Listed
- NYSE: JNJ
- Incorporated in
- New Jersey
- Headquarters
- One Johnson & Johnson Plz, New Brunswick, NJ 08933
- Industry
- Pharma & biotech
- Founded
- 1886
- Revenue FY2017
- $71.9B +3% from $70.1B
- Net income FY2025
- $26.8B +91% from $14.1B
- R&D FY2025
- $14.7B
Johnson & Johnson pays a median H-1B base of $145,000 across FY2017–2026, about 35% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Johnson & Johnson
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Gilead | 1,934 | 442 | $142k | 186 | 62% |
| Genentech | 1,679 | 333 | $142k | 103 | 56% |
| Eli Lilly | 1,620 | 848 | $136k | 353 | 73% |
| Johnson & Johnson | 556 | 118 | $160k | 25 | 80% |
| Novitium Pharma | 536 | 92 | $80k | 44 | 50% |
| Janssen | 520 | 154 | $165k | 51 | 73% |
| Teva Pharmaceuticals | 424 | 48 | $137k | 9 | 72% |
